600566.SS · 济川药业
China A-shares · RS rating 93 · As of 2026-10-14
| Price | 27.66 CNY |
|---|---|
| 1-day change | +1.5% |
| RS rating (overall / 1M / 3M / 12M) | 93 / 92 / 83 / 78 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 33 / 34 / 36 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -7.2% |
| Distance from 52-week high | +4.5% |
| Market cap (USD) | $3.6B |